SM
ESPR

Sabby Management’s Esperion Therapeutics ESPR Stock Holding History

Sabby Management’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-100
Closed -$46K – 133
2022
Q1 		$46K Buy
+100
New +$429 0.01% 130
2018
Q3 		– Sell
-370
Closed -$1.45M – 133
2018
Q2 		$1.45M Sell
370
-168
-31% -$8.49K 0.22% 50
2018
Q1 		$3.89M Buy
538
+423
+368% +$31.1K 0.46% 27
2017
Q4 		$757K Buy
+115
New +$6.19K 0.07% 89
2017
Q2 		– Sell
-320
Closed -$1.13M – 230
2017
Q1 		$1.13M Buy
+320
New +$7.33K 0.06% 126
2015
Q1 		– Sell
-206
Closed -$833 – 303
2014
Q4 		$833 Buy
+206
New +$6.31K 0.03% 167

Other funds holding ESPR

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return